Published in Health Business Week, April 2nd, 2010
"It is truly exciting to have Dr. Kaelin become a part of the Agios scientific advisory board. His pioneering insights in molecular oncology have changed the field, and he will be an outstanding addition to our SAB," said David...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2010-04-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.